Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brian Seal
Real-World Effectiveness of Brentuximab Vedotin Versus Physicians’ Choice Chemotherapy in Patients With Relapsed/Refractory Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the United Kingdom and Germany
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Health Disparities in Staging of SEER-Medicare Prostate Cancer Patients in the United States
Urology
Urology
Related publications
Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase I/Ii Study of Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Patients Treated by Chemotherapy (Ice) in Second Line Before Autologous Transplantation.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cost-Effectiveness Analysis of Consolidation With Brentuximab Vedotin for High-Risk Hodgkin Lymphoma After Autologous Stem Cell Transplantation
Cancer
Cancer Research
Oncology
Pulmonary Toxicity in Paediatric Patients With Relapsed or Refractory Hodgkin Lymphoma Receiving Brentuximab Vedotin
British Journal of Haematology
Hematology
Brentuximab Vedotin for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey
Annals of Hematology
Medicine
Hematology
PSY5 Comparing Brentuximab Vedotin Overall Survival Data to Standard of Care in Patients With Relapsed/Refractory Hodgkin Lymphoma (HL) Post-Autologous Stem Cell Transplant (ASCT)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prospective Study of Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma Patients Who Are Not Suitable for Stem Cell Transplant or Multi-Agent Chemotherapy
British Journal of Haematology
Hematology
Profile of Brentuximab Vedotin and Its Potential in the Treatment of Relapsed or Refractory Hodgkin Lymphoma
Blood and Lymphatic Cancer: Targets and Therapy
Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
